LedermannJA, BegentRHJ, BagshawKD.Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin A. Br J Cancer1988; 58: 654–7.
2.
Kuus-RachelK, GraverLS, KorawvodinLM.Will immunogenicity limit the use, efficacy and future development of therapeutic monoclonal antibodies. Clin Diagn Lab Immunol1994; 1: 365–72.
3.
LedermannJA, BegentRHJ, MaassofC.A phase 1 study of repeated therapy with radiolabelled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin A to suppress the immune response. Int J Cancer1991; 47: 659–64.
4.
ZimmerAM, RosenST, SpiesSM.Radioimmuno therapy of patients with cutaneous T-cell lymphoma using and iodine-131-labelled monoclonal antibody: analysis of retreatment following plasmapheresis. J Nucl Med1988; 29: 174–80.
5.
PedleyRB, BodenJ, KeepPA, HarwoodPJ, GreenAJ, RogersGT.Relationship between tumour size and uptake of radiolabelled anti-CEA antibody in a colon tumour xenograft. Eur J Nucl Med1987; 13: 197–202.
6.
AdamT.Radioiodination for therapy. Ann Clin Biochem1989; 26(part 3): 244–5.
